Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.01 per share
-
Shares outstanding
-
17,255,853
-
Total 13F shares
-
9,375,536
-
Share change
-
-1,464,482
-
Total reported value
-
$30,188,503
-
Price per share
-
$3.22
-
Number of holders
-
71
-
Value change
-
-$4,619,940
-
Number of buys
-
24
-
Number of sells
-
30
Institutional Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) as of Q4 2024
As of 31 Dec 2024 Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) had 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,375,536 shares of stock of the company.
Largest 10 holders included ARMISTICE CAPITAL, LLC, ACORN CAPITAL ADVISORS, LLC, Solas Capital Management, LLC, VANGUARD GROUP INC, Newtyn Management, LLC, Prosight Management, LP, BlackRock, Inc., RBF Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, and Verition Fund Management LLC.
This table shows 71 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.